According to reports, DUALITYBIO-B (09606) has announced on October 17, 2025, that the company's board has resolved to issue ordinary shares in RMB for listing on the Shanghai Stock Exchange’s STAR Market. The proposed issuance of RMB shares is subject to (including but not limited to) market conditions, further approval from the board, approval from shareholders at a general meeting, and necessary regulatory approvals. As of the announcement date, apart from the preliminary proposal regarding the issuance of RMB shares and information disclosed in this announcement, the board has no other plans concerning the proposed issuance and has not made any applications to relevant regulatory authorities regarding the proposed issuance.